thanks for info RBx.
anyone got a view on how long this will take, the unknown for me is how rare the condition presentation is to the centers and how long recruitment might take.
otherwise the trial design looks straight forward glass they are going to atleast 1800.
accept the criticism this is another phase 1, although veyonda to treatment naive patients of an albeit difficult to treat condition, with the FDA ODD potential makes it not just another phase 1 IMO.
may this be the last phase 1 Nox ever does.
Sarcoma trial to start Nov 15, page-5
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
